Positron emission tomography imaging of tumor angiogenesis and monitoring of antiangiogenic efficacy using the novel tetrameric peptide probe 64Cu-cyclam-RAFT-c(-RGDfK-)4.
about
Molecular imaging and therapy targeting copper metabolism in hepatocellular carcinomaNon-invasive imaging for studying anti-angiogenic therapy effects.In situ validation of VEGFR-2 and α v ß 3 integrin as targets for breast lesion characterization.β3 integrin promotes TGF-β1/H2O2/HOCl-mediated induction of metastatic phenotype of hepatocellular carcinoma cells by enhancing TGF-β1 signaling.Construction of expressing vectors including melanoma differentiation-associated gene-7 (mda-7) fused with the RGD sequences for better tumor targetingSynthesis and Evaluation of Novel 2-Pyrrolidone-Fused (2-Oxoindolin-3-ylidene)methylpyrrole Derivatives as Potential Multi-Target Tyrosine Kinase Receptor Inhibitors.MicroPET imaging of tumor angiogenesis and monitoring on antiangiogenic therapy with an (18)F labeled RGD-based probe in SKOV-3 xenograft-bearing mice.[¹⁸F]fluciclatide in the in vivo evaluation of human melanoma and renal tumors expressing αvβ 3 and α vβ 5 integrins.Positron emission tomography of cerebral angiogenesis and TSPO expression in a mouse model of chronic hypoxia.Longitudinal monitoring of tumor antiangiogenic therapy with near-infrared fluorophore-labeled agents targeted to integrin αvβ3 and vascular endothelial growth factor.Uniform intratumoral distribution of radioactivity produced using two different radioagents, 64Cu-cyclam-RAFT-c(-RGDfK-)4 and 64Cu-ATSM, improves therapeutic efficacy in a small animal tumor model.
P2860
Q26772332-ED7B72AD-0D53-4404-92DD-D63129AB8A7EQ30447988-7D8835C3-5553-4B42-81F7-1C159B7E95B8Q33687901-9F363348-5DBD-4A5A-A656-A41D56E3AE14Q35048745-27402E99-9616-4D1E-8EC1-09DF99B3BE9CQ36249337-BECC37C2-53AD-4A21-9252-BC48AFE9BDDAQ38754455-EE5F3B65-7CD7-44DD-8D3A-9413FF75F9D8Q38929240-B0AAE94F-01B2-4C92-BF82-9FC6CD110F31Q45287510-F4158A5D-C4B9-4613-AE40-B32AB22EAADAQ48337362-08699039-C86C-4A48-9DF9-D35F5101DC62Q51751868-B1CC1C14-9360-487A-8949-C5680429BCE0Q55442958-955059C7-AF9F-47BB-A1B6-3513A691DD2B
P2860
Positron emission tomography imaging of tumor angiogenesis and monitoring of antiangiogenic efficacy using the novel tetrameric peptide probe 64Cu-cyclam-RAFT-c(-RGDfK-)4.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Positron emission tomography i ...... 64Cu-cyclam-RAFT-c(-RGDfK-)4.
@ast
Positron emission tomography i ...... 64Cu-cyclam-RAFT-c(-RGDfK-)4.
@en
type
label
Positron emission tomography i ...... 64Cu-cyclam-RAFT-c(-RGDfK-)4.
@ast
Positron emission tomography i ...... 64Cu-cyclam-RAFT-c(-RGDfK-)4.
@en
prefLabel
Positron emission tomography i ...... 64Cu-cyclam-RAFT-c(-RGDfK-)4.
@ast
Positron emission tomography i ...... 64Cu-cyclam-RAFT-c(-RGDfK-)4.
@en
P2093
P2860
P1433
P1476
Positron emission tomography i ...... 64Cu-cyclam-RAFT-c(-RGDfK-)4.
@en
P2093
Didier Boturyn
Jean-Luc Coll
Michael Claron
Pascal Dumy
Takako Furukawa
Toshimitsu Fukumura
Tsuneo Saga
Yasuhisa Fujibayashi
Zhao-Hui Jin
P2860
P2888
P304
P356
10.1007/S10456-012-9281-1
P577
2012-05-29T00:00:00Z